Novel sugar-cholestanols generate a new therapeutic agent against peritoneal dissemination | Molecular Cancer Therapeutics
Novel sugar-cholestanols generate a new therapeutic agent against peritoneal dissemination. Takayuki Asao, Shinji Hashimoto, ... Novel sugar-cholestanols generate a new therapeutic agent against peritoneal dissemination. Takayuki Asao, Shinji Hashimoto, ... Novel sugar-cholestanols generate a new therapeutic agent against peritoneal dissemination. Takayuki Asao, Shinji Hashimoto, ... When sugar-cholestanols were added into the culture medium of cancer cells, they were incorporated into the cells through the ...http://mct.aacrjournals.org/content/6/11_Supplement/B268
A Review on Bile Acids: Effects of the Gut Microbiome, Interactions with Dietary Fiber, and Alterations in the Bioaccessibility...
Cholestanols. Cholestanes substituted in any position with one or more hydroxy groups. They are found in feces and bile. In ...https://www.bioportfolio.com/resources/pmarticle/2341628/A-Review-on-Bile-Acids-Effects-of-the-Gut-Microbiome-Interactions-with.html
stage iia non small cell carcinoma of the lung drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
Cholestanols / therapeutic use. Cholestanols / toxicity. Lactates / therapeutic use. Lactates / toxicity. Lung Neoplasms / drug ... Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Cholestanols; 0 / Lactates; 4WE915J1KX / squalamine lactate; ...http://www.bmlsearch.com/?kwr=stage+iia+non+small+cell+carcinoma+of+the+lung+drug+therapy+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1
List of MeSH codes (D04) - Wikipedia
... cholestanols MeSH D04.808.247.100.250 --- cholestanol MeSH D04.808.247.125 --- cholestanones MeSH D04.808.247.222 --- ...https://en.wikipedia.org/wiki/List_of_MeSH_codes_(D04)
Replacing Opioids: Developing drugs to treat pain | Technology Networks
The group went on to describe how a type of molecule called cholestanols disrupted this internal signaling and significantly ...https://www.technologynetworks.com/proteomics/articles/replacing-opioids-developing-drugs-to-treat-pain-289925
Patents 5686506 - 5686763
... cholestanols, stigmasterols, etc.) : The carbon is a member of an acyclic chain of exactly two carbons (e.g., 3 keto-4,17(20)- ...http://www.everypatent.com/idx/pdir2143.html
IONIZABLE CATIONIC LIPID FOR RNA DELIVERY - Patent application
... cholestanols, stigmasterols, etc.) Publication date: 2015-05-21 Patent application number: 20150141678 ...http://www.patentsencyclopedia.com/app/20150141678
Brassinosteroid signal transduction: still casting the actors. - PubMed - NCBI
Cholestanols/metabolism*. *Phytosterols/metabolism*. *Plant Growth Regulators/metabolism*. *Receptors, Cell Surface/metabolism* ...https://www.ncbi.nlm.nih.gov/pubmed/?term=10679450%5BPMID%5D
BIN4, a novel component of the plant DNA topoisomerase VI complex, is required for endoreduplication in Arabidopsis. - PubMed ...
Cholestanols/metabolism. *Colchicine/pharmacology. *DNA/metabolism. *DNA Damage. *DNA Topoisomerases, Type I/metabolism* ...https://www.ncbi.nlm.nih.gov/pubmed/?term=18055605%5BPMID%5D
A Phase IIA Trial of Continuous Five Day Infusions of MSI-1256F (Squalamine Lactate) Plus Carboplatin for Therapy of Refractory...
This phase IIa trial evaluated the efficacy and tolerability of continuous 5-day infusions of squalamine [Ohr Pharmaceutical] in combination with carboplatinhttps://adisinsight.springer.com/trials/700003271?error=cookies_not_supported&code=60017910-562c-4ee6-a98d-35147105e3bc